A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
Public ClinicalTrials.gov record NCT02067611. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase 2, multicenter, randomized, double blind (with dose), placebo controlled, parallel group, proof of concept, and dose range finding study to evaluate the efficacy, safety, and PK of X0002 spray in adult subjects with clinically symptomatic mild to moderate OA of the knee. Objectives of the study: 1. To evaluate the efficacy of X0002 spray compared to placebo for relief of knee pain in subjects with osteoarthritis (OA) of the knee; 2. To assess the safety and tolerability of multiple doses of X0002 when administered as a topical spray.
Study identification
- NCT ID
- NCT02067611
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 216 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 35 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2014 (Type not available)
- Primary completion
- Aug 2015 (Actual)
- Completion
- Apr 2016 (Actual)
- Last update posted
- Feb 7, 2018
2014 – 2016
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Fiel Family & Sports Medicine/Clinical Research Advantage Inc | Tempe | Arizona | 85283-1528 | — |
| Med Center | Carmichael | California | 95608 | — |
| Encompass Clinical Research | Spring Valley | California | 91978 | — |
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | — |
| New England Research Assoc. | Trumbull | Connecticut | 06611 | — |
| Clinical Research of South Florida | Coral Gables | Florida | 32720 | — |
| Avail Clinical Research, LLC | DeLand | Florida | 32720 | — |
| Health Awareness Inc. | Jupiter | Florida | 33458 | — |
| Suncoast Clinical Research, Inc | New Port Richey | Florida | 34652 | — |
| Columbus Regional Research Institute | Columbus | Georgia | 31904 | — |
| Clinical Trials Technology(CTT) Consultants, Inc. | Prairie Village | Kansas | 66206-1362 | — |
| Healthcare Research Network | Hazelwood | Missouri | 63042-1755 | — |
| Sundance Clinical Research, LLC | St Louis | Missouri | 63141-7068 | — |
| New Mexico Clinical Research & Osteoporosis Center, Inc. | Albuquerque | New Mexico | 87106 | — |
| Hightop Medical Research | Cincinnati | Ohio | 45224 | — |
| Prestige Clinical Research, LLC | Franklin | Ohio | 45005 | — |
| Heritage Valley Medical Group | Beaver | Pennsylvania | 15009 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Quality Research Inc | San Antonio | Texas | 78209 | — |
| Health Research of Hampton Roads, Inc | Newport News | Virginia | 23606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02067611, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 7, 2018 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02067611 live on ClinicalTrials.gov.